|

Cytoxan Clinical Trials

3 actively recruiting trials across 3 locations

Also known as: Cyclophosphamide

Pipeline

Phase 1: 1Phase 2: 2

Top Sponsors

  • Memorial Sloan Kettering Cancer Center1
  • H. Lee Moffitt Cancer Center and Research Institute1
  • Baylor College of Medicine1

Indications

  • Cancer3
  • Liver Disease1
  • Childhood Neuroblastoma1
  • Yolk Sac Tumor1
  • Wilms Tumor1

Tampa, Florida1 trial

Sequential Therapies Modeled on Evolutionary Dynamics for Breast Cancer

Moffitt Cancer Center

Phase 2

New York, New York1 trial

N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma

Memorial Sloan Kettering Cancer Center

Phase 2

Houston, Texas1 trial

Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors

Texas Children's Hospital

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.